%0 Journal Article %J Pharmacognosy Research %D 2022 %T Ayurveda: The Prominence of Herbal Medicine in Containment of COVID-19 %A Sarasa Meenakshi %A V Udaya Kumar %A Reny Sara Raju %A Sameer Dhingra %A Nitesh Kumar %A V Ravichandiran %A Krishna Murti %K Antiviral %K Ayurveda %K COVID-19 %K Immunomodulatory %K Inflammation %X

The global community is in a vulnerable and intricate state due to the COVID-19 pandemic given the lack of targeted drugs and extreme population making it an arduous journey to the public system of health care towards the extermination of the disease. The essentiality of newer compounds, novel medical instruments, and practices for diagnosis, cure, and prevention of the COVID-19 infection is the greatest concern. Since the persistent waves of COVID-19 are being observed at a variety of location across the globe, and the intensity and mutation of the virus is still possessing an inviolable threat to humanity. Along with conventional medicine, the application of traditional medicine practices using natural and herbal products has been proved effective in several disease conditions. The usage of Traditional Chinese medicine and ayurvedic medicine is used to treat COVID-19 infected patients in China and India respectively marks the contribution and effectiveness of traditional medical therapy in the restriction of the virus. The prominence of herbal products for prophylactic and symptomatic treatment for COVID-19 is notable and recommended by various organizations and governments in the world. All the pragmatic considerations and evidence to use ayurvedic practices on a large scale require further animal and robust human studies. This article reviews various practices, herbal products, effectiveness, case studies and the contribution of ayurvedic medicine, to be used to treat and restrict the viral epidemic and may further provide a forward insight into future learning, evidence compiling, and research in the respective domain.

%B Pharmacognosy Research %V 14 %P 233-240 %8 July 2022 %G eng %N 3 %9 Review Article %M 01 %& 233 %R 10.5530/pres.14.3.33